Related Experiment Video
Updated: Jul 2, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Plasma exchange in immune-mediated neuropathies
Helmar C Lehmann1, Hans-Peter Hartung, Gerd Meyer Zu Hörste
1Department of Neurology, Heinrich Heine University, Düsseldorf, Germany. helmar.lehmann@uni-duesseldorf.de
Plasma exchange is a common treatment for immune-mediated neuropathies. While effective for Guillain-Barré syndrome, its long-term use in chronic neuropathies requires further clinical trials.
Area of Science:
- Neurology
- Immunology
- Therapeutics
Background:
- Plasma exchange is a frequently employed therapeutic modality for various immune-mediated neuropathies.
- Its application spans diverse neurological disorders involving immune system dysregulation.
Purpose of the Study:
- To review the current clinical value of plasma exchange in treating immune-mediated neuropathies.
- To discuss recent advancements and ongoing research in this therapeutic area.
Main Methods:
- Systematic review of existing literature and clinical trials.
- Analysis of data on efficacy, optimal frequency, side effects, and cost-effectiveness.
Main Results:
- Plasma exchange efficacy is best documented in Guillain-Barré syndrome, with established short and long-term benefits.
- Evidence for plasma exchange in chronic immune-mediated neuropathies is less robust, with uncertainties regarding long-term efficacy and optimal treatment frequency.
Conclusions:
- Plasma exchange is a valuable treatment for Guillain-Barré syndrome.
- Further clinical trials are essential to fully evaluate the long-term efficacy of plasma exchange in chronic immune-mediated neuropathies and its role as an adjuvant therapy.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
